Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Doxifluridine

Doxifluridine

pharmaceutical raw materials
Doxifluridine structure

Doxifluridine 

structure
  • CAS No:

    3094-09-5

  • Formula:

    C9H11FN2O5

  • Chemical Name:

    Doxifluridine

  • Synonyms:

    Uridine,5′-deoxy-5-fluoro-;5′-Deoxy-5-fluorouridine;Ro 21-9738;Doxifluridine;5-Fluoro-5′-deoxyuridine;5-Fluorodesoxyuridine;5′-DFUR;Furtulon;5′-dFUrd;Flutron;Fulturon;1226642-64-3

  • Categories:

    Active Pharmaceutical Ingredients  >  Antineoplastic Agents

Description

Doxifluridine(Ro 21-9738; 5'-DFUR) is a thymidine phosphorylase activator for PC9-DPE2 cells with IC50 of 0.62 μM. IC50 value: 0.62 μM(PC9-DPE2 cell).Target: Nucleoside antimetabolite/analogDoxifluridine is a fluoropyrimidine derivative and oral prodrug of the antineoplastic agent 5-fluorouracil (5-FU) with antitumor activity. Doxifluridine, designed to circumvent the rapid degradation of 5-FU by dihydropyrimidine dehydrogenase in the gut wall, is converted into 5-FU in the presence of p


Doxifluridine is a pyrimidine 5'-deoxyribonucleoside that is 5-fluorouridine in which the hydroxy group at the 5' position is replaced by a hydrogen. It is an oral prodrug of the antineoplastic agent 5-fluorouracil. Designed to circumvent the rapid degradation of 5-fluorouracil by dihydropyrimidine dehydrogenase in the gut wall, it is converted into 5-fluorouracil in the presence of pyrimidine nucleoside phosphorylase. It has a role as an antimetabolite, an antineoplastic agent and a prodrug. It is an organofluorine compound and a pyrimidine 5'-deoxyribonucleoside.|Doxifluridine has been investigated for the treatment of Stomach Cancer.|Doxifluridine is a fluoropyrimidine derivative and oral prodrug of the antineoplastic agent 5-fluorouracil (5-FU) with antitumor activity. Doxifluridine, designed to circumvent the rapid degradation of 5-FU by dihydropyrimidine dehydrogenase in the gut wall, is converted into 5-FU in the presence of pyrimidine nucleoside phosphorylase. 5-FU interferes with DNA synthesis and subsequent cell division by reducing normal thymidine production and interferes with RNA transcription by competing with uridine triphosphate for incorporation into the RNA strand.

Doxifluridine Basic Attributes

246.19

246.19

221-440-1

V1JK16Y2JP

DTXSID2022967

C978

2934999090

Characteristics

99.1

-1.7

White Solid

1.6±0.1 g/cm3

190 °C

1.605

>36.9 [ug/mL]

-20°C Freezer

LD50 (14 day) in mice or rats (mg/kg): >1000 i.v.: >2000 s.c.; in male, female mice, male, female rats (mg/kg): >5000, >5000, 3471, 3390 orally (Shimizu)

D25 +18.4° (c = 0.419 in water)

Safety Information

IRRITANT, IRRITANT-HARMFUL

NONH for all modes of transport

2

36/37/38

26-36-24/25

YU7526000

Xi

Irritant

Stable at normal temperatures and pressures.

P201, P202, P210, P233, P240, P241, P242, P243, P261, P264, P271, P272, P273, P280, P281, P302+P352, P303+P361+P353, P304+P312, P304+P340, P305+P351+P338, P308+P313, P312, P321, P332+P313, P333+P313, P337+P313, P362, P363, P370+P378, P391, P403+P233, P403+P235, P405, P501

H226

|Danger|H226 (20%): Flammable liquid and vapor [Warning Flammable liquids]|P201, P202, P210, P233, P240, P241, P242, P243, P261, P264, P271, P272, P273, P280, P281, P302+P352, P303+P361+P353, P304+P312, P304+P340, P305+P351+P338, P308+P313, P312, P321, P332+P313, P333+P313, P337+P313, P362, P363, P370+P378, P391, P403+P233, P403+P235, P405, and P501|Aggregated GHS information provided by 6 companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

Agents that are used to stimulate appetite. These drugs are frequently used to treat anorexia associated with cancer and AIDS. (See all compounds classified as Appetite Stimulants.)|Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)|Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)

5'-deoxy-5'-fluorouridine

Doxifluridine Use and Manufacturing

antineoplastic, pyrimidine antimetabolite

Computed Properties

Molecular Weight:246.19
XLogP3:-1.7
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:6
Rotatable Bond Count:1
Exact Mass:246.06519962
Monoisotopic Mass:246.06519962
Topological Polar Surface Area:99.1
Heavy Atom Count:17
Complexity:399
Defined Atom Stereocenter Count:4
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Drug Function and Efficacy

Extract from the above information

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

Recommended Suppliers of Doxifluridine

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.